Do you routinely prescribe anticoagulation for patients on active chemotherapy?

This is dependent on the risk factors of the patient for the development of VTE. Recently published ASCO guidelines (JCO 2019) incorporated the additional recommendation of VTE prophylaxis for high risk outpatients receiving chemotherapy with either eliquis, xarelto, or LMWH. The Khorana scoring system is described as the tool used, but there is acknowledgement that there are other tools that may be useful as well, some disease specific. I cannot say I have adopted this across the board for all ...